Targeted KEAP1 disruption enhances antioxidant defense and mesenchymal stromal cell therapy for chronic limb-threatening ischemia.
Saved in:
| Title: | Targeted KEAP1 disruption enhances antioxidant defense and mesenchymal stromal cell therapy for chronic limb-threatening ischemia. |
|---|---|
| Authors: | Shin EJ; ToolGen, Inc., Seoul, Republic of Korea., Choi Y; ToolGen, Inc., Seoul, Republic of Korea., Jeon EJ; Cellartgen, Inc., Seoul 03722, Republic of Korea., Lee KI; ToolGen, Inc., Seoul, Republic of Korea., Lee KJ; ToolGen, Inc., Seoul, Republic of Korea., Son YJ; ToolGen, Inc., Seoul, Republic of Korea., Son MJ; ToolGen, Inc., Seoul, Republic of Korea., Kim S; ToolGen, Inc., Seoul, Republic of Korea., Cho SW; Cellartgen, Inc., Seoul 03722, Republic of Korea; Department of Biotechnology, Yonsei University, Seoul 03722, Republic of Korea; Center for Nanomedicine, Institute for Basic Science (IBS), Seoul 03722, Republic of Korea. Electronic address: seungwoocho@yonsei.ac.kr., Lee JY; ToolGen, Inc., Seoul, Republic of Korea; Department of Health Science and Technology, Samsung Advanced Institute of Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul 06351, Republic of Korea; Cell and Gene Therapy Institute (CGTI), Research Institute for Future Medicine, Samsung Medical Center, Seoul 06351, Republic of Korea. Electronic address: jyjlee0930@gmail.com. |
| Source: | Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2026 Jul 01; Vol. 34 (7), pp. 3949-3961. Date of Electronic Publication: 2026 Mar 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41792998 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Targeted KEAP1 disruption enhances antioxidant defense and mesenchymal stromal cell therapy for chronic limb-threatening ischemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Shin+EJ%22">Shin EJ</searchLink>; ToolGen, Inc., Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Choi+Y%22">Choi Y</searchLink>; ToolGen, Inc., Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jeon+EJ%22">Jeon EJ</searchLink>; Cellartgen, Inc., Seoul 03722, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+KI%22">Lee KI</searchLink>; ToolGen, Inc., Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+KJ%22">Lee KJ</searchLink>; ToolGen, Inc., Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Son+YJ%22">Son YJ</searchLink>; ToolGen, Inc., Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Son+MJ%22">Son MJ</searchLink>; ToolGen, Inc., Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+S%22">Kim S</searchLink>; ToolGen, Inc., Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Cho+SW%22">Cho SW</searchLink>; Cellartgen, Inc., Seoul 03722, Republic of Korea; Department of Biotechnology, Yonsei University, Seoul 03722, Republic of Korea; Center for Nanomedicine, Institute for Basic Science (IBS), Seoul 03722, Republic of Korea. Electronic address: seungwoocho@yonsei.ac.kr.<br /><searchLink fieldCode="AU" term="%22Lee+JY%22">Lee JY</searchLink>; ToolGen, Inc., Seoul, Republic of Korea; Department of Health Science and Technology, Samsung Advanced Institute of Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul 06351, Republic of Korea; Cell and Gene Therapy Institute (CGTI), Research Institute for Future Medicine, Samsung Medical Center, Seoul 06351, Republic of Korea. Electronic address: jyjlee0930@gmail.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100890581%22">Molecular therapy : the journal of the American Society of Gene Therapy</searchLink> [Mol Ther] 2026 Jul 01; Vol. 34 (7), pp. 3949-3961. <i>Date of Electronic Publication: </i>2026 Mar 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100890581 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1525-0024 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215250016%22">15250016 </searchLink><i>NLM ISO Abbreviation: </i>Mol Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41792998 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ymthe.2026.03.005 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3949 Titles: – TitleFull: Targeted KEAP1 disruption enhances antioxidant defense and mesenchymal stromal cell therapy for chronic limb-threatening ischemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Shin EJ – PersonEntity: Name: NameFull: Choi Y – PersonEntity: Name: NameFull: Jeon EJ – PersonEntity: Name: NameFull: Lee KI – PersonEntity: Name: NameFull: Lee KJ – PersonEntity: Name: NameFull: Son YJ – PersonEntity: Name: NameFull: Son MJ – PersonEntity: Name: NameFull: Kim S – PersonEntity: Name: NameFull: Cho SW – PersonEntity: Name: NameFull: Lee JY IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2026 Jul 01 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1525-0024 Numbering: – Type: volume Value: 34 – Type: issue Value: 7 Titles: – TitleFull: Molecular therapy : the journal of the American Society of Gene Therapy Type: main |
| ResultId | 1 |